Navigation Links
Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit
Date:2/22/2013

are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com

Forward-Looking Statements

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements.

CONTACT:

Jeff Ramson
Investor Relations
ProActive Capital Group
646-863-6341

Sarah Kelly
Director of Corporate Communications
(+86) 21 54069990 
sarah.kelly@ce
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cellular Biomedicine Group Announces ISO 9001:2008 Certification and ISO-14644 Cleanroom Certification
2. Cellular Therapy Market and Cord Blood Market 2013 Industry Research Report: MarketResearchReports.Biz
3. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
4. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
5. Proteins shine a brighter light on cellular processes
6. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
7. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
8. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
9. A 300 Million Euro Boost for Biomedicine in Berlin
10. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
11. Photonics21 Group Announces Prize for Photonics with Industrial Impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 ... Book Bureau presents Innovative Drug ... Formulation Technology Licensing Opportunities for ... ) There are ... controlled release drugs approved all ...
(Date:6/19/2013)... 2013 Express Diagnostics Int’l, Inc., manufacturer ... that it has received Class III medical device license ... DrugCheck® NxStep Onsite Drug Screen Cup in ... screening device in near-patient settings, such as physicians’ offices. ... Health Canada Class III approval for 24 different drugs ...
(Date:6/18/2013)... 18, 2013 In support of Swiss ... Consulate General of Switzerland in New York is pleased ... MS Tûranor PlanetSolar , to Manhattan. PlanetSolar is ... Expedition 2013 tour with scientists on board from the ... d’Aboville, runs exclusively on energy from the sun and ...
(Date:6/18/2013)... 18, 2013 DuPont welcomes 48 of ... annual DuPont National AgriScience Teachers Ambassador Academy this week ... Chestertown, Md. , The NATAA “Ag Academy” ... is a special project of the National FFA ... Educators (NAAE) . The highly recommended agriscience teachers, ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3
... , CINCINNATI, Sept. 18 LCA-Vision Inc. (Nasdaq: ... correction services under the Lasik Plus (R) brand, announces that ... a member of the company,s board of directors effective September ... ophthalmology industry. Management of daily operations will be the ...
... N.J., Sept. 17 Regado Biosciences, a privately held company ... announced today that the European Patent Office (EPO) has notified ... claims directed to oligonucleotide modulators of blood coagulation factor aptamers ... Company,s portfolio extends the scope and breadth of Regado,s intellectual ...
... , , , , ... The US Food and Drug Administration (FDA) has approved Valturna(R) ... two key points within the renin system, also known as the ... This is the first approval for Valturna, which is indicated for ...
Cached Biology Technology:LCA-Vision Announces CEO Resignation 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 3Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 2Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 3Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 4Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 5Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 6Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 7
(Date:6/19/2013)... MOUNTAIN VIEW, Calif. , June 20, 2013 ... the personalized cosmeceuticals market, Frost & Sullivan recognizes ... Sullivan Award for New Product Innovation. geneOnyx leverages ... point-of-care testing to create an on-the-spot genetic test ... only a single-step DNA collection procedure from saliva ...
(Date:6/19/2013)... The protected area network in Tanzania is playing a ... as they move west in response to climate and ... University of York., Using data on savannah birds from ... Tanzanian bird distributions over recent decades - the researchers ... stones as they move to areas further west where ...
(Date:6/19/2013)... , June 19, 2013   ... clinical laboratory diagnostics technology for conducting on-demand, ... diabetes testing, as well as analysis of ... and platelet counts. The new system enables ... lab results for physicians and their patients, ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4Protected areas provide African birds with stepping stones to survival 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4
... target muscle may reverse the symptoms of a rare ... mice conducted by medical geneticists at Duke University Medical ... Pompe disease usually die before they reach the age ... targeting corrective genes to muscles may have application in ...
... the flow of water molecules through the brain can help ... if a patient's tumor will shrink, a new study shows. ... developed the assessment, which they call a functional diffusion map. ... diffusion, or movement, of water through the brain and mapped ...
... historic anthropology expedition to Ethiopia's Lake Turkana basin, researchers ... time are roughly 195,000 years old. The researchers ... we all trace to an ancient line that first ... recently as 50,000 years ago. , Ian McDougall of ...
Cached Biology News:Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 2Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 3New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 3New Clues Add 40,000 Years to Age of Human Species 2New Clues Add 40,000 Years to Age of Human Species 3New Clues Add 40,000 Years to Age of Human Species 4
... particle based purification systems provide high speed ... sample. They offer increased throughput and reproducible ... KingFisher, KingFisher mL and KingFisher 96, covering ... Each system consists of an instrument, specially ...
... PROTECT FROM MOISTURE. AVOID FREEZE/THAW CYCLES. ... cells in vitro by DNA ... their anti-histone-facilitated detection. In this assay, mono- ... binding proteins. Anti-Histone 3 (H3) biotin-labeled antibody ...
... optimized cell lines in combination with ... nucleofection parameters. Nucleofector Kits are only ... Device., Different cell lines can be ... efficiencies and viabilities are given in ...
... solution or in a gel piece, we can ... be digested to produce a mixture of peptides. ... determined by MALDI-TOF, and the amino acid sequences ... will be determined by MALDI-TOF/TOF. The masses and ...
Biology Products: